*ST Jiyao (300108.SZ): Received a court decision to extend the pre-restructuring period

Gelonghui on May 27丨*ST Jiyao (300108.SZ) announced that the company received the “Decision” delivered by Tonghua Intermediate Court. The main contents are as follows: On May 22, 2024, the temporary manager of Ji Yao Holding Group Co., Ltd. and the company applied to Tonghua Intermediate Court to extend the pre-restructuring period of Ji Yao Holdings. The Tonghua Intermediate Court believes that the application of the temporary manager and company of Ji Yao Holding Group Co., Ltd. complied with the relevant regulations and decided to extend the pre-restructuring period of Ji Yao Holdings by three months until August 27, 2024.

Gelonghui FinanceMay 27 05:17 ET

ST Pharmaceutical (300108.SZ): The company's stock trading was subject to delisting risk warning, stock trading suspended

Gelonghui announced on April 28 | ST Jiyao (300108.SZ). After an audit, the company's net assets at the end of the 2023 period were negative. It touches upon the provisions of section 10.3.1 (2) of the “Shenzhen Stock Exchange GEM Stock Listing Rules”: “The net assets at the end of the audited fiscal year were negative, or the net assets at the end of the most recent fiscal year were negative after retroactive restatement”. The company's 2023 audit agency Central Certified Public Accountants (Special General Partnership) issued an audit report where it was unable to express an opinion on the company's 2023 financial statements, touching on “Shenzhen

Gelonghui FinanceApr 28 09:12 ET

ST Pharmaceutical (300108.SZ): Net loss of 40.85 million yuan in the first quarter

Gelonghui, April 28 | ST Jiyao (300108.SZ) released its first quarter report. Operating income was 75.46 million yuan, up 5.36% year on year, net loss of 40.85 million yuan, net loss of 37.94 million yuan, basic earnings per share -0.0613 yuan.

Gelonghui FinanceApr 28 04:27 ET

Sihuan Pharmaceutical Holdings Unit Forms Consortium for Ji Yao Restructuring

Sihuan Pharmaceutical Holdings (HKG:0460) unit Longyu Hongda Investment Management formed a consortium with other parties for the restructuring of Ji Yao Holding (SHE:300108) following its bankruptcy

MT NewswiresFeb 8 02:49 ET

ST Jiyao (300108.SZ): Received a decision to initiate pre-restructuring and appoint a temporary manager

Gelonghui November 27丨ST Jiyao (300108.SZ) announced that through a decision of the Tonghua Intermediate Court, pre-restructuring procedures were initiated for the company during the bankruptcy and restructuring preparation stage, and the bankruptcy and restructuring and liquidation team of Jiyao Holding Group Co., Ltd., which was founded by the Meihekou Municipal People's Government, was appointed as the interim manager.

Gelonghui FinanceNov 27, 2023 07:17 ET

[BT Financial Report Instantaneous Analysis] ST Jiyao's 2023 Quarterly Report: Operating income and profit declined, net cash flow declined sharply

This financial report was announced on 2023-10-25 18:30:26 ST Jiyao (stock code: 300108) is an enterprise group centered on the pharmaceutical and health industry. Its main business includes the pharmaceutical industry, pharmaceutical business, pharmaceutical research and development, medical care, and pharmaceutical industry investment. Its pharmaceutical industry mainly produces Chinese and Western proprietary medicines, biopharmaceuticals, and health food products, covering a variety of dosage forms. The company has about 170 pharmaceutical production codes, including national medical insurance products, medical insurance catalogue products, and national exclusive varieties or dosage forms. In addition, the company also has new drug projects under development. From assets

businesstimes cnOct 30, 2023 02:43 ET